Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05609552 · ClinicalTrials.gov registry record
Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 10
- Enrollment target
NCT05609552: Completed study, sponsored by Johns Hopkins University.
NCT05609552 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05609552 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This is an observational study that will examine the pretomanid pharmacokinetics (PK) in tuberculosis (TB) patients. Dynamic 18F-pretomanid PET/CT will be performed after intravenous injection of 18F-pretomanid to determine multi-compartment, noninvasive determination of pretomanid PK in TB patients.
Interventions
- COMBINATION_PRODUCT 18F-Pretomanid PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2025-10-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05609552
The ClinicalTrials.gov registry entry for NCT05609552 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 18F-Pretomanid PET/CT is the first listed.
NCT05609552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05609552 about?
NCT05609552 is a clinical study titled "Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET". This is an observational study that will examine the pretomanid pharmacokinetics (PK) in tuberculosis (TB) patients. Dynamic 18F-pretomanid PET/CT will be performed after intravenous injection of 18F-pretomanid to determine multi-compartment, noninvasive determination of pretomanid PK in TB patients...
What is the current status of trial NCT05609552?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2023-05-22. Estimated completion is 2025-10-28.
What interventions are being tested in trial NCT05609552?
The interventions under investigation include: 18F-Pretomanid PET/CT (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05609552?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.